2026 NPPES data Radiation Oncology Physician NPI 1417954124 MD
Verify on CMS →

MARK HARRISON, MD

Radiation Oncology Physician in MCALLEN, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
88
Medicare Part D claims · 44 beneficiaries · Radiation Oncology Physician avg: 186
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$588.28
34 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK HARRISON, MD is a Radiation Oncology Physician ([object Object]) practicing in MCALLEN, Texas with a Medicare Part D prescribing footprint of 88 claims across 44 beneficiaries — 20% brand-name prescribing . Industry payments of $588.28 across 34 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK HARRISON, MD filed 88 Medicare Part D claims in 2023 across MCALLEN, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK HARRISON, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK HARRISON, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 07/07/2005

NPI 1417954124

Primary specialty

Radiation Oncology Physician

Mid-sized

6,018 US NPIs in this specialty

Medicare Part D claims

88 53% vs specialty avg

2023 prescription claims

Specialty avg: 186

Specialty distribution in Texas

How Radiation Oncology Physician compares to other specialties among Texas providers

Texas providers

Radiation Oncology Physician share within Texas

1. Radiation Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Radiation Oncology Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Radiation Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Radiation Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Radiation Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Radiation Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK HARRISON, MD is a Radiation Oncology Physician provider practicing in MCALLEN, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1417954124. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK HARRISON, MD appears in the CMS NPPES registry as a Radiation Oncology Physician provider holding MD credentials at 620 S BROADWAY ST, MCALLEN, TX, 78501, with a listed phone of (956) 682-9680. NPI 1417954124 was issued on 07/07/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HARRISON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 88 prescription claims written by this provider, covering 44 Medicare beneficiaries and totaling roughly $4K in drug spend, split 20% brand-name and 80% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Radiation Oncology Physician is a mid-sized specialty nationwide, with 6,018 enrolled providers across 52 states and an average of 186 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

620 S BROADWAY ST
MCALLEN, TX 78501

Provider Details

NPI 1417954124
Specialty Radiation Oncology Physician
Credentials MD
Gender Male
NPI Issued 07/07/2005

Hospital and facility affiliations

Facilities where MARK HARRISON, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

VALLEY CANCER ASSOCIATES PA
HARLINGEN, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK HARRISON, MD. Source: openpaymentsdata.cms.gov.

Total received

$588

Largest payer

Bayer Healthcare Pharmaceuticals Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MARK HARRISON, MD. To verify MARK HARRISON, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK HARRISON, MD — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 88 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

88
Total Claims
$4K
Total Drug Cost
44
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
114
Total Day Supply
2,902
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$756
Generic Drug Cost
$3K
Antibiotic Claims
22

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
2.14
Gender Split
36% female / 64% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
24
Mometasone Furoate
16
Ssd
Silver Sulfadiazine
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Radiation Oncology Physician Overview

How MARK HARRISON, MD fits within the Radiation Oncology Physician landscape nationally.

6,018
Radiation Oncology Physician Providers in US
52
States with Radiation Oncology Physician
186
Avg Claims per Provider

MARK HARRISON, MD's 88 claims are below the specialty average of 186.

Nearby Radiation Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as HARRISON.

Compare Radiation Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK HARRISON, MD's specialty?
MARK HARRISON, MD specializes in Radiation Oncology Physician and practices in MCALLEN, Texas. Credentials: MD.
How much does MARK HARRISON, MD prescribe under Medicare Part D?
In 2023, MARK HARRISON, MD wrote 88 Medicare Part D claims totaling $4K in drug costs for 44 beneficiaries.
Where is MARK HARRISON, MD located?
MARK HARRISON, MD is located at 620 S BROADWAY ST, MCALLEN, TX, 78501. Phone: (956) 682-9680.
What is MARK HARRISON, MD's NPI number?
MARK HARRISON, MD's National Provider Identifier (NPI) is 1417954124, issued on 07/07/2005.
Does MARK HARRISON, MD prescribe more brand-name or generic drugs?
MARK HARRISON, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $756 in brand drug costs.
How many Radiation Oncology Physician providers are there in the US?
There are 6,018 Radiation Oncology Physician providers across 52 states in the US. The average Radiation Oncology Physician provider writes 186 Medicare Part D claims per year.
What drugs does MARK HARRISON, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK HARRISON, MD's most frequently prescribed drugs include Tamsulosin Hcl, Mometasone Furoate, Ssd. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK HARRISON, MD accept Medicare?
MARK HARRISON, MD appears in CMS Medicare data with 88 Part D claims and 44 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK HARRISON, MD's credentials?
MARK HARRISON, MD's NPI is 1417954124 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology